FDA Adverse Event Malfunction Summary report: N

REMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION

MDR report key: 23479369 · Received November 5, 2025

Report

Report Number
3016798778-2025-00127
Event Type
Malfunction
Date Received
November 5, 2025
Date of Event
October 4, 2025
Report Date
November 5, 2025
Manufacturer
MILLYARD ADVANCED MEDICAL PRODUCTS, LLC
Product Code
QJY
UDI-DI
00850017421035
PMA / PMN Number
K202690
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
NURSE
Health Professional
Yes

Narratives

Description of Event or Problem · 0

AN INITIAL EVENT NOTIFICATION WAS RECEIVED BY UNITED THERAPEUTICS DRUG SAFETY ON 06-OCT-2025 FROM ACCREDO SPECIALTY PHARMACY AND FORWARDED TO MILLYARD ADVANCED MEDICAL PRODUCTS, LLC, ON 07-OCT-2025. IT WAS REPORTED THAT THE PATIENT HAD DIFFICULTY WITH THE REMUNITY PUMP AND SUBCUTANEOUS SITE PLACEMENT. THE PATIENT PRESENTED TO THE EMERGENCY ROOM AFTER BEING OFF INFUSION FOR APPROXIMATELY ONE HOUR DUE TO UNRESOLVED OCCLUSION ALARMS ON THE REMUNITY PUMP, DESPITE HAVING A FUNCTIONAL BACKUP REMUNITY PUMP. THE PATIENT REFUSED A SUBCUTANEOUS SITE CHANGE AND WAS ULTIMATELY ADMITTED TO THE HOSPITAL FOR INTRAVENOUS REMODULIN THERAPY. NO COMPONENTS OR FURTHER INFORMATION RELATED TO THE REPORTED EVENT HAVE BEEN MADE AVAILABLE TO MILLYARD ADVANCED MEDICAL PRODUCTS, LLC, FOR ADDITIONAL INVESTIGATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2648577 REMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION INFUSION PUMP QJY MILLYARD ADVANCED MEDICAL PRODUCTS, LLC DKPI-11042-001 00850017421035

Patients

Seq Age Sex Outcome Treatment
1 45 YR Male Hospitalization ALBUTEROL SULFATE HFA| AMITRIPTYLINE USP| BENZONATATE| BREZTRI AEROSPHERE| CLONIDINE USP| ELIQUIS| FENOFIBRATE| GABAPENTIN USP| KETAMINE HCL USP| KETOPROFEN USP| LECITHIN| LIDOCAINE HCL USP| MIRTAZAPINE| POLOXAMER GEL| POTASSIUM CHLORIDE| SOD CHLORIDE| TADALAFIL| TORSEMIDE